1. corneal cross linker & accessories 2. ricrolin & ricrolin te
אלפא-נטו בע"מ - רופא
בוטרנס 5
rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 5 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.
בוטרנס 10
rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 10 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.
בוטרנס 20
rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 20 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.
בוטרנס 15
rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 15 mg - buprenorphine
זיבוקסיד 600 מג
pfizer pfe pharmaceuticals israel ltd - linezolid - טבליה - linezolid 600 mg - linezolid - linezolid - therapy is indicated only when an organism resistant to all other antibiotics is suspected. zyvoxid is indicated in adult and pediatric patients for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: 1) pneumonia - community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (mdrsp). 2) skin and soft tissue infections including diabetic foot infections. 3) enterococcal infections. combination therapy may be indicated if a concomitant gram negative pathogen is documented or suspected.
זיבוקסיד 2 מגמל
pfizer pfe pharmaceuticals israel ltd - linezolid - תמיסה לאינפוזיה - linezolid 2 mg/ml - linezolid - linezolid - therapy is indicated only when an organism resistant to all other antibiotics is suspected. zyvoxid is indicated in adult and pediatric patients for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: 1) pneumonia - community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (mdrsp). 2) skin and soft tissue infections including diabetic foot infections. 3) enterococcal infections. combination therapy may be indicated if a concomitant gram negative pathogen is documented or suspected.
זיבוקסיד 600 מג
pfizer pfe pharmaceuticals israel ltd - linezolid - טבליה - linezolid 600 mg - linezolid
זיבוקסיד 600 מג
pfizer pfe pharmaceuticals israel ltd - linezolid - טבליה - linezolid 600 mg - linezolid
לינזו - אבניר
bioavenir ltd, israel - linezolid - טבליות מצופות פילם - linezolid 600 mg - linezolid